Background
==========

Moxibustion is an East Asian therapeutic method that uses the heat generated by burning herbal preparations containing *Artemisia vulgaris*to stimulate acupuncture points \[[@B1]\]. According to the theory of traditional medicine, heat is usually applied to acupuncture points during moxibustion to cure diseases by regulating the function of meridians and visceral organs. A possible explanation for how moxibustion works is that the heat stimulates acupuncture points, which increases *qi*circulation and relieves *qi*stagnation, leading to an improved disease state \[[@B2]\].

Acupuncture stimulation, which involves thrusting or twisting needles, results in various biochemical reactions that can have effects throughout the body. Unlike acupuncture, moxibustion uses heat stimulation at various temperature levels, ranging from mild skin warming to tissue damage from burning. This heat stimulation can yield inflammatory responses and induce vascular changes \[[@B2]\].

Although moxibustion is often used as a symptomatic treatment for a wide range of conditions in clinical practice, e.g., arthritis, gastrointestinal problems, gynaecological complaints and stroke rehabilitation, its clinical effectiveness remains uncertain \[[@B3]-[@B5]\], and many experts doubt its biological plausibility. Numerous clinical trials have emerged; however, their results are contradictory. Thus, SRs assessing the summary of this evidence may bring clarification. To date, several such articles have been published. Unfortunately, however, the conclusions drawn in these publications are also conflicting.

This overview is aimed at summarising and critically evaluating all SRs on moxibustion as a symptomatic treatment for any condition. Our ultimate goal is to provide clinicians with clearer guidance regarding the value of this therapy.

Methods
=======

The following databases were searched on July 22, 2010 without language restrictions: Medline, EMBASE, AMED, CINHAL, the Cochrane Library, six Korean Medical Databases (Korean Studies Information, DBPIA, Korea Institute of Science and Technology Information, Korea Education and Research Information Service, KoreaMed and Korean National Assembly Library) and Chinese Databases (CNKI). In addition, our extensive departmental files were searched by hand. The keywords used in the search were (systematic review OR meta-analysis) AND (moxa OR moxibustion). Articles were included if they related to a formal SR or meta-analysis on any type of moxibustion as a treatment for any type of condition. Reviews, comments and overviews without a systematic methods section were excluded.

To be included, the SR had to be concerned specifically with the effectiveness of moxibustion and include evidence from at least two controlled clinical trials. SRs evaluating moxibustion together with acupuncture without separate evaluation of each approach were excluded.

Key data were extracted independently by two authors (MSL & JWK) according to predefined criteria, including conditions, number of primary studies, methodological quality of the primary studies, conclusion of each SR, and data related with searching. Disagreements were resolved by discussion between the authors. Judgement about the quality of the primary studies was adopted from the respective SRs. The Overview Quality Assessment Questionnaire (OQAQ) was used to evaluate the methodological quality of all included SRs \[[@B6]\]. In the OQAQ, the score ranges from 1 to 7. A score of 3 or less was considered as indicative of major flaws, whereas a score of 5 or more suggested only minor flaws. The two authors did these assessments independently, and discrepancies were settled by discussion.

Results
=======

Our searches generated 99 hits, and 10 articles met our inclusion criteria (Figure [1](#F1){ref-type="fig"}, Table [1](#T1){ref-type="table"}) \[[@B3],[@B7]-[@B15]\]. These studies included a wide range of conditions, including cancer \[[@B11]\], ulcerative colitis \[[@B10]\], stroke rehabilitation \[[@B12]\], several pain conditions \[[@B13]\], constipation \[[@B14]\], hypertension \[[@B15]\] and breech presentation \[[@B7]-[@B9]\]. Approximately half of the SRs arrived at a positive conclusion \[[@B8],[@B9],[@B11]-[@B13]\]. Most of the SRs were of good quality, but all had to rely on poor quality primary studies.
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###### 

Systematic reviews on moxibustion for health care

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  First author\       Condition               No. of primary studies   Methodological quality of primary studies^†^   Quality of SR\   Meta-analysis                                                                                             Conclusion (quote)^†^                                                                                           Authors\' result^†^
  Year (Ref)                                                                                                          OQAQ\*                                                                                                                                                                                                                                     
  ------------------- ----------------------- ------------------------ ---------------------------------------------- ---------------- --------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------- ---------------------
  Kim\                Various conditions      48 RCTs                  Poor                                           5                Ulcerative colitis\                                                                                       Our results did not support the effectiveness of moxibustion in specific disease                                **+/-**
  (2010) \[[@B3]\]                                                                                                                     1) Moxa vs. drug (2 RCTs), RR, 2.20, 95% CIs,1.37 to 3.52, P = 0.001, I^2^= 0%\                                                                                                                                           
                                                                                                                                       2) Moxa vs. wait control (2 RCTs), RR, 1.19, 95CIs, 0.88 to 1.60, P = 0.26, I^2^= 40%\                                                                                                                                    
                                                                                                                                       3) Moxa plus postual care vs. postual care, RR, 1.51, 95%CIs, 1.10 to 2.08, P = 0.01, I^2^= 86%                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                 

  Coyle\              Breech presentation     3 RCTs                   Poor                                           7                None                                                                                                      There is insufficient evidence to support \...                                                                  **+/-**
  (2005) \[[@B7]\]                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                 

  Li\                 Breech presentation     17(10 RCTs and 7 CCTs)   Poor                                           7                1\) Moxa vs. no treatment (3 RCTs), RR, 135, 95%CIs, 1.20 to 1.51, P \< 0.00001\                          \...tend to be effective\...                                                                                    \+
  (2009) \[[@B8]\]                                                                                                                     2) Moxa vs. knee-chest position (3 RCTs), RR, 1.30, 95%CIs, 0.95 to 1.79, P = 0.1\                                                                                                                                        
                                                                                                                                       3) Moxa plus other treatment vs. other treatment (2 RCTs), RR, 1.36, 95%CIs, 1.21 to 1.54, P \< 0.00001                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                 

  Vas\                Breech presentation     7 RCTs                   Variable                                       7                Moxa vs. control (6 studies), RR, 1.36, 95% CIs, 1.17 to 1.58, P \< 0.0001                                Moxibustion at \...BL67 has been shown to produce a positive effect\...                                         \+
  (2009) \[[@B9]\]                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                 

  Lee\                Ulcerative colitis      5 RCTs                   Poor                                           7                Moxa vs. drug (5 RCTs), RR, 1.24, 95% CIs, 1.11 to 1.38, P \< 0.0001, I^2^= 16%                           Current evidence is insufficient \...                                                                           **+/-**
  (2010) \[[@B10]\]                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                 

  Lee\                Cancer                  5 RCTs                   Poor                                           6                Moxa plus chemotherapy vs. chemotherapy\                                                                  The evidence is limited to suggest moxibustion is an effective supportive cancer care in nausea and vomiting.   \+
  (2010) \[[@B11]\]                                                                                                                    1) Response rate (4 RCTs), RR, 1.04, 95% CIs, 0.94 to 1.15, P = 0.43, I^2^= 26%\                                                                                                                                          
                                                                                                                                       2) Side effects (2 RCTs), RR, 0.38, 95% CIs, 0.22 to 0.65, P = 0.0005, I^2^= 0%                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                 

  Lee\                Stroke rehabilitation   9 RCTs                   Poor                                           5                Moxa vs. standard care\                                                                                   \...found limited effectiveness of moxibustion as an adjunct to standard care\...                               \+
  (2010) \[[@B12]\]                                                                                                                    1) Motor function (3RCTs), SMD, 0.72, 95% CIs, 0.37 to 1.08, P \< 0.0001, I^2^= 5%\                                                                                                                                       
                                                                                                                                       2) Activities of daily living (3 RCTs), SMD, 0.51, 95%CIs,\                                                                                                                                                               
                                                                                                                                       -0.08 to 1.10, P = 0.09, I^2^= 62%                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                 

  Lee\                Pain conditions         4 RCTs                   Poor                                           7                Osteoarthritis: Moxa vs. drug (2 RCTs), RR, 1.11, 95%CIs, 1.02 to 1.21, P = 0.02, I^2^= 3%                \...limited evidence \... in the management of osteoarthritis of the knee and other pain condition              \+
  (2010) \[[@B13]\]                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                 

  Lee\                Constipation            3 RCTs                   Poor                                           3                None                                                                                                      \... evidence is scarce and insufficient to suggest\...                                                         **+/-**
  (2010) \[[@B14]\]                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                 

  Kim\                Hypertension            4 RCTs                   Poor                                           5                None                                                                                                      There is insufficient\...                                                                                       **+/-**
  (2010) \[[@B15]\]                                                                                                                                                                                                                                                                                                                                              
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^†^This was relied on the original authors\' judgment;\* Overview quality assessment questionnaire (OQAQ). The overall score is from 1 to 7. OQAQ ≤ 3: having extensive or major flaws; 5 ≤ OQAQ: having minor or minimal flaws. +: overall positive; -: fail to show effectiveness; +/-: unclear. SR: systematic review; RCT: randomized controlled trial; CCT: non-randomized controlled trial.

For one particular condition, breech presentation, three SRs were available \[[@B7]-[@B9]\]. Two showed clearly positive results \[[@B8],[@B9]\], whereas the other cast doubt on the clinical relevance of the effect due to the small number of included trials \[[@B7]\]. For the studies regarding cancer (10), stroke (11) and pain (12), the conclusions were cautiously positive. Equivocal conclusions emerged from the SRs on ulcerative colitis \[[@B10]\], constipation \[[@B14]\] and hypertension \[[@B15]\]. One SR evaluated the effects of moxibustion on various conditions and failed to arrive at a clearly positive conclusion \[[@B3]\].

Discussion
==========

Our overview shows that several SRs on moxibustion have been published. The fact that most of them were recent indicates that the scientific interest in moxibustion is growing. Even though most of the reviews are of high quality \[[@B3],[@B7]-[@B15]\], they are based on few clinical trials that were not well controlled. Several SRs have arrived at positive overall conclusions; however, some of the studies regarding breech presentation contradict each other \[[@B7]-[@B9]\]. This can be explained by the time difference amongst the three SRs. The more up-to-date SR includes four to seven more rigorous and positive studies than the first SR \[[@B8],[@B9]\]. Thus, the sum of the best evidence to date seems to suggest that moxibustion is effective for breech presentation.

Positive conclusions were also reached for the treatment for nausea and vomiting in cancer patients \[[@B11]\], stroke rehabilitation \[[@B12]\] and pain conditions \[[@B13]\]. Unfortunately, these SRs were based mostly on poor quality primary studies. Thus, considerable uncertainty about the value of moxibustion for these indications persists.

Three SRs relating to ulcerative colitis \[[@B10]\], constipation \[[@B14]\] and hypertension \[[@B15]\] were of poor quality, and all relied on a small number of flawed studies. It therefore seems fair to say that the value of moxibustion is not well-documented for any of these conditions.

In essence, this means that the effectiveness of moxibustion is currently not well-documented for several conditions, which is in sharp contrast to the many claims made by the proponents of this therapeutic modality, including those practicing traditional Chinese medicine or complementary and alternative medicine.

SRs on moxibustion have stated their studies to be limited by the often poor quality of the primary data. Our analysis confirms this view. Many of the primary moxibustion trials originate from China (data not shown); Vickers et al. demonstrated that virtually 100% of Chinese acupuncture trials are positive \[[@B16]\], which seems to be equally applied to moxibustion, an acupuncture-like intervention. This casts considerable doubt on the reliability of these studies. Collectively, these facts limit the conclusiveness of SRs on moxibustion, thereby leaving a level of uncertainty. SRs have been criticised for being often unable to provide specific guidance. Yet, even if uncertainty prevails, SRs have the important function of mapping areas of doubt. Thus, as pointed out above, our overview highlights areas of research in which investment in further clinical trials would be fruitful.

Thus our overview of SRs suggests that future moxibusition-research should consider all necessary measure to minimize bias including development of possible sham or placebo moxibustion. We recommend to follow the CONSORT guidelines when designing clinical trials of moxibustion \[[@B17]\]. Similarly, SRs of moxibustion should abide by the PRISMA guidelines to reduce the risk of bias \[[@B18]\].

Our overview has several important limitations. Even though our search strategy was thorough, we cannot completely exclude the notion that relevant articles were missed. By evaluating systematic reviews rather than clinical trials, important details of the primary studies may have been lost. Most importantly, the poor quality of the primary data and the systematic reviews is regrettable. Collectively, these limitations limit the conclusiveness of our findings.

In conclusion, this overview of SRs suggests that moxibustion is effective for correcting breech presentation, whereas for other conditions, the evidence does not reach a firm conclusion because of several limitations. All SRs are, however, based on studies with a high risk of bias. Therefore, considerable uncertainty remains about the therapeutic value of moxibustion.
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